BACKGROUND: Family history is a major risk factor for prostate cancer (PCa), suggesting a genetic component to the disease. However, traditional linkage and association studies have failed to fully elucidate the underlying genetic basis of familial PCa. METHODS: Here, we use a candidate gene approach to identify potential PCa susceptibility variants in whole exome sequencing data from familial PCa cases. Six hundred ninety-seven candidate genes were identified based on function, location near a known chromosome 17 linkage signal, and/or previous association with prostate or other cancers. Single nucleotide variants (SNVs) in these candidate genes were identified in whole exome sequence data from 33 PCa cases from 11 multiplex PCa families (3 cases/family). RESULTS: Overall, 4,856 candidate gene SNVs were identified, including 1,052 missense and 10 nonsense variants. Twenty missense variants were shared by all three family members in each family in which they were observed. Additionally, 15 missense variants were shared by two of three family members and predicted to be deleterious by five different algorithms. Four missense variants, BLM Gln123Arg, PARP2 Arg283Gln, LRCC46 Ala295Thr and KIF2B Pro91Leu, and one nonsense variant, CYP3A43 Arg441Ter, showed complete co-segregation with PCa status. Twelve additional variants displayed partial co-segregation with PCa. CONCLUSIONS: Forty-three nonsense and shared, missense variants were identified in our candidate genes. Further research is needed to determine the contribution of these variants to PCa susceptibility.
BACKGROUND: Family history is a major risk factor for prostate cancer (PCa), suggesting a genetic component to the disease. However, traditional linkage and association studies have failed to fully elucidate the underlying genetic basis of familial PCa. METHODS: Here, we use a candidate gene approach to identify potential PCa susceptibility variants in whole exome sequencing data from familial PCa cases. Six hundred ninety-seven candidate genes were identified based on function, location near a known chromosome 17 linkage signal, and/or previous association with prostate or other cancers. Single nucleotide variants (SNVs) in these candidate genes were identified in whole exome sequence data from 33 PCa cases from 11 multiplex PCa families (3 cases/family). RESULTS: Overall, 4,856 candidate gene SNVs were identified, including 1,052 missense and 10 nonsense variants. Twenty missense variants were shared by all three family members in each family in which they were observed. Additionally, 15 missense variants were shared by two of three family members and predicted to be deleterious by five different algorithms. Four missense variants, BLM Gln123Arg, PARP2 Arg283Gln, LRCC46 Ala295Thr and KIF2B Pro91Leu, and one nonsense variant, CYP3A43 Arg441Ter, showed complete co-segregation with PCa status. Twelve additional variants displayed partial co-segregation with PCa. CONCLUSIONS: Forty-three nonsense and shared, missense variants were identified in our candidate genes. Further research is needed to determine the contribution of these variants to PCa susceptibility.
Authors: J P Struewing; P Hartge; S Wacholder; S M Baker; M Berlin; M McAdams; M M Timmerman; L C Brody; M A Tucker Journal: N Engl J Med Date: 1997-05-15 Impact factor: 91.245
Authors: Angie Stone; Luke D Ratnasinghe; Ginny L Emerson; Rama Modali; Terri Lehman; Gail Runnells; Alindria Carroll; Weleetka Carter; Samuel Barnhart; Al A Rasheed; Graham Greene; Don E Johnson; Christine B Ambrosone; Fred F Kadlubar; Nicholas P Lang Journal: Cancer Epidemiol Biomarkers Prev Date: 2005-05 Impact factor: 4.254
Authors: Jianfeng Xu; Latchezar Dimitrov; Bao-Li Chang; Tamara S Adams; Aubrey R Turner; Deborah A Meyers; Rosalind A Eeles; Douglas F Easton; William D Foulkes; Jacques Simard; Graham G Giles; John L Hopper; Lovise Mahle; Pal Moller; Tim Bishop; Chris Evans; Steve Edwards; Julia Meitz; Sarah Bullock; Questa Hope; Chih-Lin Hsieh; Jerry Halpern; Raymond N Balise; Ingrid Oakley-Girvan; Alice S Whittemore; Charles M Ewing; Marta Gielzak; Sarah D Isaacs; Patrick C Walsh; Kathleen E Wiley; William B Isaacs; Stephen N Thibodeau; Shannon K McDonnell; Julie M Cunningham; Katherine E Zarfas; Scott Hebbring; Daniel J Schaid; Danielle M Friedrichsen; Kerry Deutsch; Suzanne Kolb; Michael Badzioch; Gail P Jarvik; Marta Janer; Leroy Hood; Elaine A Ostrander; Janet L Stanford; Ethan M Lange; Jennifer L Beebe-Dimmer; Caroline E Mohai; Kathleen A Cooney; Tarja Ikonen; Agnes Baffoe-Bonnie; Henna Fredriksson; Mika P Matikainen; Teuvo Lj Tammela; Joan Bailey-Wilson; Johanna Schleutker; Christiane Maier; Kathleen Herkommer; Josef J Hoegel; Walther Vogel; Thomas Paiss; Fredrik Wiklund; Monica Emanuelsson; Elisabeth Stenman; Bjorn-Anders Jonsson; Henrik Gronberg; Nicola J Camp; James Farnham; Lisa A Cannon-Albright; Daniela Seminara Journal: Am J Hum Genet Date: 2005-06-29 Impact factor: 11.025
Authors: Ethan M Lange; Christiane M Robbins; Elizabeth M Gillanders; Siqun Lilly Zheng; Jianfeng Xu; Yunfei Wang; Kirsten A White; Bao-Li Chang; Lindsey A Ho; Jeffrey M Trent; John D Carpten; William B Isaacs; Kathleen A Cooney Journal: Hum Genet Date: 2006-11-21 Impact factor: 4.132
Authors: Ilir Agalliu; Erika M Kwon; Daniel Zadory; Laura McIntosh; Joseph Thompson; Janet L Stanford; Elaine A Ostrander Journal: Clin Cancer Res Date: 2007-02-01 Impact factor: 12.531
Authors: Chunying Li; Zhibin Hu; Jiachun Lu; Zhensheng Liu; Li-E Wang; Adel K El-Naggar; Erich M Sturgis; Margaret R Spitz; Qingyi Wei Journal: Cancer Date: 2007-08-15 Impact factor: 6.860
Authors: Julie A Douglas; Albert M Levin; Kimberly A Zuhlke; Anna M Ray; Gregory R Johnson; Ethan M Lange; David P Wood; Kathleen A Cooney Journal: Cancer Epidemiol Biomarkers Prev Date: 2007-06-21 Impact factor: 4.254
Authors: Daniel C Koboldt; Krishna L Kanchi; Bin Gui; David E Larson; Robert S Fulton; William B Isaacs; Aldi Kraja; Ingrid B Borecki; Li Jia; Richard K Wilson; Elaine R Mardis; Adam S Kibel Journal: Cancer Epidemiol Biomarkers Prev Date: 2016-08-02 Impact factor: 4.254
Authors: Elisa M Ledet; Emmanuel S Antonarakis; William B Isaacs; Tamara L Lotan; Colin Pritchard; A Oliver Sartor Journal: Prostate Date: 2019-11-05 Impact factor: 4.104
Authors: Alisa M Goldstein; Elizabeth M Gillanders; Melissa Rotunno; Rolando Barajas; Mindy Clyne; Elise Hoover; Naoko I Simonds; Tram Kim Lam; Leah E Mechanic Journal: Cancer Epidemiol Biomarkers Prev Date: 2020-05-28 Impact factor: 4.254
Authors: Christina Backes; Christian Harz; Ulrike Fischer; Jana Schmitt; Nicole Ludwig; Britt-Sabina Petersen; Sabine C Mueller; Yoo-Jin Kim; Nadine M Wolf; Hugo A Katus; Benjamin Meder; Rhoikos Furtwängler; Andre Franke; Rainer Bohle; Wolfram Henn; Norbert Graf; Andreas Keller; Eckart Meese Journal: Oncotarget Date: 2015-03-20
Authors: Danielle M Karyadi; Milan S Geybels; Eric Karlins; Brennan Decker; Laura McIntosh; Amy Hutchinson; Suzanne Kolb; Shannon K McDonnell; Belynda Hicks; Sumit Middha; Liesel M FitzGerald; Melissa S DeRycke; Meredith Yeager; Daniel J Schaid; Stephen J Chanock; Stephen N Thibodeau; Sonja I Berndt; Janet L Stanford; Elaine A Ostrander Journal: Oncotarget Date: 2017-01-03